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Sandra Söderholm1†, Petteri Hintsanen2†, Tiina Öhman1, Tero Aittokallio2 and Tuula A Nyman1*Abstract
Background: It is possible to identify thousands of phosphopeptides and –proteins in a single experiment with
mass spectrometry-based phosphoproteomics. However, a current bottleneck is the downstream data analysis
which is often laborious and requires a number of manual steps.
Results: Toward automating the analysis steps, we have developed and implemented a software, PhosFox, which
enables peptide-level processing of phosphoproteomic data generated by multiple protein identification search
algorithms, including Mascot, Sequest, and Paragon, as well as cross-comparison of their identification results. The
software supports both qualitative and quantitative phosphoproteomics studies, as well as multiple between-group
comparisons. Importantly, PhosFox detects uniquely phosphorylated peptides and proteins in one sample compared
to another. It also distinguishes differences in phosphorylation sites between phosphorylated proteins in different
samples. Using two case study examples, a qualitative phosphoproteome dataset from human keratinocytes and a
quantitative phosphoproteome dataset from rat kidney inner medulla, we demonstrate here how PhosFox facilitates
an efficient and in-depth phosphoproteome data analysis. PhosFox was implemented in the Perl programming
language and it can be run on most common operating systems. Due to its flexible interface and open source
distribution, the users can easily incorporate the program into their MS data analysis workflows and extend the
program with new features. PhosFox source code, implementation and user instructions are freely available from
https://bitbucket.org/phintsan/phosfox.
Conclusions: PhosFox facilitates efficient and more in-depth comparisons between phosphoproteins in case–
control settings. The open source implementation is easily extendable to accommodate additional features for
widespread application use cases.
Keywords: Database searching, Phosphoproteomics, LC-MS/MS, Data processing and analysisBackground
The human proteome is estimated to include up to
500,000 phosphorylation sites [1], but only a fraction of the
potential phosphorylation sites have been identified so far.
The advances in phosphopeptide enrichment procedures
and high-throughput mass spectrometry instrumentation
have led to rapid development of MS-based phosphopro-
teomics during the last few years, and currently thousands
of phosphorylation sites can be detected from a single* Correspondence: tuula.nyman@helsinki.fi
†Equal contributors
1Institute of Biotechnology, University of Helsinki, P.O. Box 65 (Viikinkaari 1),
FI-00014 Helsinki, Finland
Full list of author information is available at the end of the article
© 2014 Söderholm et al.; licensee BioMed Cen
Creative Commons Attribution License (http:/
distribution, and reproduction in any medium
Domain Dedication waiver (http://creativecom
article, unless otherwise stated.sample. In MS-based phosphoproteomics, protein identifi-
cation and phosphopeptide mapping relies on database
search engines, including Mascot [2], Sequest [3], X!Tan-
dem [4], OMSSA [5], Andromeda/Maxquant [6], and Para-
gon [7]. However, the user is often limited with the choice
of search engine(s) to those that are compatible with the
raw data from the MS-instrument used.
There are several software solutions and bioinformatic
tools designed for managing and extracting information
from phosphoproteomics experiments, such as ArMone
[8], ProteoConnections [9], PhosphoSiteAnalyzer [10],
and PeptideDepot [11]. Additionally, there are protein
modification site localization algorithms which are inte-
grated in search engines and interfaces, for exampletral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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ware solutions can be successfully used in certain applica-
tions, to our knowledge, there are no software solutions
for directly comparing phosphoproteomic results on the
phosphopeptide level between multiple different database
search engines and/or between stimulated versus control
samples. We have previously developed a tool named
Compid [14] to integrate and compare proteomics data
from Mascot and Paragon, but this software does not take
into account modifications, such as phosphorylation, and
cannot thus distinguish between phosphorylated proteins
and peptides or their non-phosphorylated counterparts.
To meet these limitations, we developed and imple-
mented a software tool, PhosFox, which enables peptide-
level processing of phosphoproteomic data generated
by several protein identification search algorithms
(including Mascot, Sequest, and Paragon), as well as
between-algorithm comparisons and multiple between-
group comparisons. Moreover, adding support for other
post-translational modifications is possible with the
current implementation of PhosFox, and to demon-
strate this we have included the possibility to process
also acetylation with PhosFox. The open source andFigure 1 An example of uniquely phosphorylated peptide (A) and wo
The crosses mark the samples from which the corresponding peptides have b
that occurs only in the case sample: these peptides are deemed to be unique
considered as the same peptide in the report (counted as two) –despite havi
identical phosphosites. Their shared sequence is reported. The black peptides
(bolded black S) has been identified once in both the case and the control sa
is uniquely phosphorylated (bolded blue S) in the control sample.efficient implementation is easily extendable to pro-
mote its wide application to large-scale phosphopeptide
analyses.
Results and Discussion
In this work, we have created a new analysis tool, Phos-
Fox, for processing and comparing phosphoproteomic
data from multiple samples and several different data-
base search algorithms. It is especially designed to find
the phosphopeptide identifications from search engine
results, and to distinguish uniquely phosphorylated pep-
tides between different samples. Similarly to reporting
phosphorylated peptides, PhosFox is also able to process
acetylated peptides. The term ‘uniquely phosphorylated
protein’ is used for describing a protein with at least one
uniquely phosphorylated peptide, which has uniquely
been matched to that particular protein in a particular
sample. A ‘uniquely phosphorylated peptide’ is a phos-
phopeptide with a unique phosphorylation or phosphory-
lations either in the case or control sample (see Figure 1A
for an example). This classification not only facilitates the
discovery of differences in protein phosphorylation sites,
but also improves the downstream analyses in the searchrkflows for qualitative and quantitative data processing (B, C).
een identified. The red peptides have a phosphoserine (bolded red S)
ly phosphorylated in the case sample. Note that the red peptides are
ng slightly different amino acid sequence lengths – because they have
are not uniquely phosphorylated, because the same phosphosite
mples. Again, their shared sequence is reported. The single blue peptide
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for qualitative and quantitative data processing are repre-
sented in Figure 1B and C. PhosFox allows the user to
choose which datasets belong to the “control group” and
which to the “case group”. In most quantitative experi-
ments, the control and case groups have been combined
before the database search step; in the case of iTRAQ [15]
or SILAC [16] labeling, the samples have already been
pooled before the LC-MS/MS analysis. An additional
FASTA file containing protein sequences is needed for
mapping the peptide sequences, and database files are re-
quired in order to identify modification sites described in
the literature.
The program outputs HTML reports with lists of
phosphopeptides, including their phosphorylation differ-
ences between control and case groups, as well as be-
tween the database search engines. Additionally, the user
can choose to produce a log file (as a plain text file) to
report possible warnings. For instance, from this file the
user sees if some of the input files have not been identi-
fied by the program, and if there are multiple matches
for a certain peptide sequence with more than one pro-
tein included in the reference sequence database. An ex-
ample of a standard PhosFox report can be seen in
Figure 2. The PhosFox report contains: the protein id,
the protein name and description, the peptide sequence
with the modified amino acid(s) underlined, and the
position of the modification site(s) on the protein se-
quence, as well as further information whether the
modification site is described in the databases used or if
it is “novel” (in that case the sites are in bold type). Add-
itionally, the text color coding in the rows indicates
whether the modified peptide is unique to case (redFigure 2 An example of a PhosFox report. The report contains: the prot
peptide sequence with the modified amino acid(s) underlined, and the positi
information whether the modification is novel (marked as bold). The followin
(in this example Paragon and Mascot) the peptide has been identified and w
in the rows indicates whether the modified peptide is unique to case (red) or
The numbers of modified amino acids on the peptides are also listed in the ocolored text) or control (blue colored text) or whether it
is found in both case and control (black colored text).
The numbers of modified amino acids (serines, threo-
nines, tyrosines, and lysines) on the peptide are also
listed in the output report. The search engine statistics
include search engine-specific files of the uniquely modi-
fied proteins and all modified peptides identified in the
samples.
As the first case study example of the use of Phos-
Fox, we analyzed and compared two phosphoproteome
datasets from human keratinocytes; an untreated control
sample and a case sample transfected with a polyinosinic-
polycytidylic acid (poly I:C) which mimics viral dsRNA-
infection resulting in pro-inflammatory responses and
apoptosis in human keratinocytes, responses characteristic
for viral infection [17]. The experimental workflow is
based on a previously published protocol [18] and is de-
scribed in Figure 3. Briefly, the phosphopeptides were
fractionated and enriched with strong cation exchange
chromatography (SCX) combined with immobilized metal
affinity chromatography (IMAC) before nanoLC-MS/MS
analysis and database searches. Two biological replicates
were analyzed, and the raw MS-data was searched sep-
arately with the Mascot and Paragon database search
algorithms. When the search results from Mascot and
Paragon (see Additional file 1: Table S1 for the search
results and Additional file 2: Table S2 for a summarized
table of phosphorylated and unphosphorylated peptide
spectral matches) were manually compiled with Micro-
soft Excel, a total of 925 phosphorylated proteins were
identified in the control sample and 929 in the case
sample (Figure 4). The number of unique phosphopro-
teins was 154 in the control and 158 in the case sample.ein accession number (id), the protein name and description, the
on of the modifications on the protein sequence, as well as further
g columns indicate in which sample(s) and by which search algorithm
hether it is unique to case or control. Additionally, the text color coding
control (blue) or whether it is found in both case and control (black).
utput report. S = serine, T = threonine, Y = tyrosine, K = lysine.
Figure 3 Experimental workflow for the preparation of the
qualitative phosphoproteomics samples.
Figure 4 Phosphoprotein and -peptide identification results
from the qualitative phosphoproteomics samples after manual
compilation of the database search results, as well as after
automatic processing with PhosFox. With manual compilation,
158 unique phosphoproteins for the case sample, and 154 unique
phosphoproteins for the control sample were identified. With PhosFox,
611 unique phosphopeptides for the case sample, and 612 unique
phosphopeptides for the control sample were identified, and 1380
phosphopeptides were identified from both control and case samples.
The identical 1380 phosphopeptides across the control and case samples
were discarded for further processing. The unique phosphopeptides
resulted in identification of 426 unique phosphoproteins from the
case, and 420 unique phosphoproteins from the control sample.
From these, 151 proteins were identified in both samples with
differences in phosphorylation sites.
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both samples include identically phosphorylated pro-
teins, but also proteins with different phosphorylation
profiles in control and case samples, and finding the
phosphopeptide-level differences for these proteins with
manual compilation is very laborious and error-prone.
When the same samples were processed with PhosFox, we
identified a total of 2,605 different (non-redundant) phos-
phopeptides, with 2,532 phosphorylated serine (85.2%),
418 phosphorylated threonine (14.1%), 15 phosphorylated
tyrosine (0.5%), and eight phosphorylated lysine (0.2%)
residues (see Additional file 3: Table S3 for the PhosFox
report). The relative abundances of the phosphorylated
residues compare well to the published data [19,20].
Altogether, PhosFox identified 1,992 phosphopeptides
from the control and 1,991 from the case sample, with
1,380 phosphopeptides being identical between the sam-
ples. The identical phosphopeptides across the samples
were not chosen for further processing and biological in-
terpretation. The 612 unique phosphopeptides in thecontrol sample (not found in the case sample) were linked
to 420 proteins and the 611 unique phosphopeptides in
the case sample (not found in the control sample) to 426
proteins. The identified peptides and their phosphoryl-
ation sites, for each sample and search engine separately,
are included in Additional file 4: Table S4. The unique
phosphoproteins identified from the control and case
samples by Mascot and Paragon, are shown in Additional
file 5: Table S5. In total 13 different acetylated peptides
were also identified from the samples (see Additional
file 3: Table S3 for the PhosFox report of the acetylated
peptides). The Mascot and Paragon confidence scores
for these acetylated peptides are shown in Additional
file 6: Table S6. As a second case study example, we an-
alyzed a previously published quantitative phosphoproteo-
mic data from rat kidney inner medulla [21]. Similarly to
the first case study example, the results show the advan-
tage of using PhosFox compared to manual compilation
(Additional file 7: Figure S1).
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subsequently be analyzed for any associations with exist-
ing molecular information. Bioinformatic tools such as In-
genuity Systems Pathway Analysis (IPA) (https://analysis.
ingenuity.com), Cytoscape [22] (www.cytoscape.org), or
ExPlain (www.biobase-international.com) can be used for
signaling network and pathway analyses. These down-
stream analyses usually rely on protein-level information,
such as protein access numbers or gene names. Here,
we used IPA for mapping proteins onto existing net-
works and pathways and classifying the proteins based
on gene ontology (GO) annotations as well as KEA, a
kinase enrichment analysis tool [23], to gain biological
insight into the phosphoproteome data from our HaCaT
keratinocyte experiments. The IPA analysis results of the
manually processed datasets as well as the PhosFox-
processed datasets are shown in Table 1. The identifiedTable 1 Top-ranked canonical pathways and networks after d
samples
A.
Manual compilation PhosFo
Pathways p-value
Role of BRCA1 in DNA damage 0.0018 DNA m
Cell cycle: G2/M DNA damage checkpoint regulation 0.0061 Cyclins
Mismatch repair in eukaryotes 0.0082 Role of
Phosphatidylethanolamine biosynthesis III 0.0087 Endome
DNA damage-induced 14-3-3σ signaling 0.012 ATM sig
Networks score
Cell death and survival, cell cycle, nervous system
development and function
21 Cellular
and sur
Cell cycle, DNA replication, recombination and repair,
cell death and survival
19 Gene ex
RNA post-transcriptional modification, cell morphology,
cellular compromise
19 Cell cyc
B.
Manual compilation PhosFo
Pathways p-value
ATM signaling 1.25E-04 Epithelia
GADD45 signaling 4.85E-04 Remode
DNA damage-induced 14-3-3σ signaling 4.85E-04 Sertoli c
Role of CHK proteins in cell cycle checkpoint control 1.1E-03 ATM sig
Cell cycle: G2/M DNA damage checkpoint regulation 5.34E-03 Germ ce
Networks score
Cell cycle, DNA replication, recombination, and repair,
gene expression
45 Cell mo
RNA post-transcriptional modification, cell cycle, cellular
movement
21 Cellular
and rep
Cellular development, cellular movement, connective
tissue disorders
19 Organis
develop
The IPA top-ranked canonical pathways and networks for the manually compiled an
of the qualitative phosphoproteomic case study example.canonical pathways and networks are different in the
manually compiled case and control datasets compared
to their PhosFox-processed counterparts. This indicates
that the two ways of processing the phosphoproteomic
data leads to different biological interpretation. The
PhosFox-processed phosphoproteomic data includes de-
tailed information of changes in the phosphorylation sta-
tus of proteins in a sample compared to another. On the
other hand, manual comparison, which is performed at
the protein level, provides only information about which
proteins are phosphorylated or not in one sample com-
pared to another.
The top-ranked network identified from PhosFox-
processed dsRNA-stimulated case dataset is associated
with cellular assembly and organization, cellular com-
promise, cell death and survival (Table 1A and Figure 5).
This network includes MAPK (ERK, ERK1/2 and Jnk)sRNA-stimulation of human keratinocytes and control
x
p-value
ethylation and transcriptional repression signaling 0.0012
and cell cycle regulation 0.0027
BRCA1 in DNA damage 0.0031
trial cancer signaling 0.0085
naling 0.013
score
assembly and organization, cellular compromise, cell death
vival
36
pression, cell signaling, post-translational modification 34
le, cellular movement, gene expression 17
x
p-value
l adherens junction signaling 5.65E-06
ling of epithelial adherens junctions 1.26E-04
ell-sertoli cell junction signaling 1.78E-04
naling 3.80E-04
ll-sertoli cell junction signaling 8.43E-04
score
rphology, cellular function and maintenance, cell cycle 39
assembly and organization, DNA replication, recombination,
air, cell morphology
37
mal survival, organ morphology, respiratory system
ment and function
37
d PhosFox-processed dsRNA-stimulated datasets (A) and control datasets (B)
Figure 5 The top-ranked IPA network of the PhosFox-processed case dataset of the qualitative phosphoproteomic case study example.
The most significant network from the PhosFox-processed case dataset (426 proteins) associated with cellular assembly and organization, cellular
compromise, cell death and survival. The red nodes are proteins found to be phosphorylated only in the case sample (included in the manually
compiled 158 unique phosphoproteins), whereas the violet nodes are proteins that have both common phosphopeptides in the control and case
sample, as well as unique phosphopeptides in the case sample identified by PhosFox. The white nodes are included in the network through the
IPA knowledge database and not found in the sample, but known to be in the network. The signaling networks were supported by at least one
curated annotation from the Ingenuity Pathways Knowledge Base (Ingenuity® Systems, www.ingenuity.com). Solid and dotted lines indicate direct
and indirect molecular interactions, respectively. The shape of the nodes indicates the molecular class. The color coding of the edges are: pink,
regulation of binding; green, expression; red, activation; violet, protein-protein interactions; black, inhibition; orange, molecular cleavage; blue,
phosphorylation/activation; light blue, transcription.
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indirectly interacting with phosphoproteins detected
from the case dataset. The MAPK and Akt family ki-
nases were not directly found in the phosphoproteomic
data, but these are known to be central players in many
signaling pathways, and to target proteins regulating
various cell processes. Their presence in the top-ranked
network and their connections to proteins from the
PhosFox-detected dsRNA-stimulated case dataset is there-
fore plausible. In contrast, the manually compiled case
dataset lacks completely this top-ranked network and
several of its interacting proteins. This further high-
lights that PhosFox has substantial impact on the re-
sults of the downstream analyses, and that the PhosFox
processing significantly adds the amount of biological
information that can be extracted from the phospho-
proteome data.
Viruses are able to manipulate a variety of host-cell sig-
nal transduction pathways. The biological impact of the
dsRNA stimulation versus no stimulation was studied in
more detail with KEA, a kinase enrichment analysis tool
[23]. The proteins with unique phosphorylation sites in
the control and case samples were analyzed separately,
and the best ranked kinases, kinase families, and kinase
classes for these datasets are shown in Additional file 8:
Table S7. Out of the 445 different kinases included in the
KEA knowledgebase, substrates for 140 kinases were iden-
tified in the case dataset and substrates for 160 kinases inthe control dataset. The dsRNA-stimulated dataset in-
cluded more significantly enriched substrates for MAPK3
(ERK1) and MAPK8 (JNK1), compared to the control
dataset. Moreover, substrates for kinases with known roles
in regulation of infection were enriched in the case data-
set, but not in the control dataset (p-value < 0.01). One of
these kinases was protein kinase C beta type (PRKCB1),
which is involved in immunity, apoptosis and NFκB sig-
naling pathways [24]. Serine/threonine-protein kinase
MARK1 is active in cell polarity, microtubule dynamics
and Wnt signaling [25] and PRKDC (DNA-dependent
protein kinase catalytic subunit) is known as a molecular
sensor of DNA damage [26].
MAPK and PI3K/Akt signaling events regulate re-
sponses to extracellular stimuli including viral infections,
but also various cellular activities such as cell metabol-
ism and proliferation [27,28]. Cyclins and cell cycle regu-
lation is included as one of the top-ranked pathways in
the case dataset (Table 1A). Also other phosphoproteomic
studies with focus on viral infections have demonstrated
alterations in phosphorylation of proteins included in
these signaling pathways [20,29–31], suggesting that these
pathways have an important role in host-response against
viral infection.
Conclusions
At present, thousands of phosphopeptides and –proteins
can be identified in a single experiment with high-
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these studies is the downstream data analysis which is
often laborious; in particular, the comparative analysis of
the identified phosphopeptides between different sam-
ples and the comparison of identification results from
different search engines often requires multiple, partially
manual steps. To this end, we have developed PhosFox,
which enables an automated and integrated phosphopro-
teomic data analysis. PhosFox compares phosphopeptide
results generated with various database search engines
across multiple sample groups, such as those with differ-
ent treatments or time points. PhosFox supports both
quantitative and qualitative phosphoproteomic data, and
includes special features such as categorization of such
phosphopeptides that are unique either to control or
case group, or common to both groups. In conclusion,
PhosFox facilitates efficient and more in-depth compari-
sons between phosphoproteins in case–control settings.
The open source implementation is easily extendable to
accommodate additional features for widespread applica-
tion use cases, such as a motif-finding option, which
would provide valuable information about the kinases that
are phosphorylating the identified phosphorylation sites,
leading to greater understanding of the functional impacts
that these modifications have on cellular processes.
Methods
PhosFox software tool
The phosphopeptide data analysis program PhosFox was
implemented in the Perl programming language. Phos-
Fox is free software and can be run on most common
operating systems, including Windows. Due to its flex-
ible interface and open source distribution, the users can
easily incorporate the program into their MS data ana-
lysis workflows and extend the program with new fea-
tures. PhosFox source code, implementation and user
instructions are available at https://bitbucket.org/phint-
san/phosfox.
PhosFox has been designed so that the user can dir-
ectly import the database search results as its input. The
input data is imported in plain text format, either as
comma-separated values (CSV) or tab-separated values
(TSV). PhosFox supports the most common file formats
and contents exported by the proteomic software being
used for analyzing the MS results and performing the
database searches. For example, the Mascot search re-
sults can directly be converted to CSV files. Paragon and
Sequest generated peptide search results can be saved as
TSV files. Moreover, if the database searches have been
carried out through the Proteome Discoverer (Thermo
Scientific) interface, the peptide spectral matches (PSMs)
can be exported as plain text format files.
The user can import an arbitrary number of input files
(peptide lists) for the analysis. Every input file is definedas either “case” (e.g. stimulated sample) or “control” (e.g.
nonstimulated sample). If multiple search result files are
added, the files are grouped and processed as one batch.
The user can specify cut-off values for multiple quality
scores, such as Mascot ion score or Paragon peptide
confidence level. PhosFox does not test the confidence
of phosphorylation assignments to particular amino
acids in the peptide sequence matches, but the user can
set a threshold for scores generated by modification site
localization algorithms incorporated in search engines,
such as Mascot delta [12] or PhosphoRS [13].
PhosFox detects phosphorylated and acetylated amino
acid residues for each peptide, which have been defined in
the settings file (by default serine, threonine, tyrosine, and
lysine), using the post-translational modification field in
the corresponding input file. Non-phosphorylated and
non-acetylated peptides are discarded from further pro-
cessing. As a unique feature of the tool, each phosphory-
lated (or acetylated) peptide is examined whether it is
uniquely modified in the case or the control sample (see
Figure 1A for details). A ‘uniquely phosphorylated peptide’
is a phosphopeptide that has a unique phosphorylation or
phosphorylations either in the case or control sample.
Peptides in quantitative datasets are treated similarly
to peptides in qualitative sets: each peptide is checked
for “enrichment” in either case or control sample by
comparing the relative amount of detected peptides
against a user-specified threshold. For example, the user
can specify that if a phosphopeptide has more than a
two-fold difference in the case sample, relative to the
control sample, it is considered as enriched in the case
sample. Such peptides are treated by PhosFox as if they
were identified in a (qualitative) case sample. Similar
strategy is used for identifying peptides enriched in the
control sample.
In cases where multiple search engines are used, Phos-
Fox can also compare similarities and differences be-
tween the results from the different search engines. Each
input file is attributed to a specific search engine. If
there are multiple search engines specified, a peptide is
deemed uniquely phosphorylated in the case sample
(resp. control) only if it has been detected in the case
(control) sample by at least one search engine and not
detected in the control (case) sample by any search en-
gine. Furthermore, PhosFox divides unique phosphopro-
teins into different search engine-specific files, thus
facilitating the extraction of either supporting or com-
plementary information about identifications between
the different search engines.
Finally, PhosFox reports novel phosphorylations (and
acetylations) to the user by comparing the identified
sites against those reported in the UniProt, PHOSIDA
and PhosphoSitePlus databases. The program outputs
HTML reports with lists of peptides, including their
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as well as between the database search engines.
PhosFox is freely available online at: https://bitbucket.
org/phintsan/phosfox. The homepage provides installa-
tion instructions and a user manual, and here it is pos-
sible to download and extract the distribution package,
which includes all the required Perl modules. PhosFox is
platform independent, but requires Perl version 5.6 or
newer. This is already installed in most Unixes and
unix-like operating systems (GNU/Linux, BSDs, OS X).
For Microsoft Windows, we recommend Strawberry
Perl, or the precompiled binary executable (see instruc-
tions on the homepage). Protein sequences in FASTA
format are needed, and at the moment UniProt and
NCBI RefSeq FASTA formats are supported. The de-
tected peptide lists can be imported in plain text format
(see the manual for details for supported file types), and
a minimum of one case file and one control file is re-
quired. PhosFox can optionally detect acetylations and
phosphorylations that have been described in the litera-
ture before. This feature is enabled by downloading and
installing separate database files from the PhosFox web
site. PhosFox is free software and requires no licensing
either from academic or non-academic users. The source
code can be redistributed and/or modified under the
GNU General Public License or Artistic License.
Qualitative phosphoproteome samples
Human keratinocytes, HaCaT cells (from ATCC) were
transfected with 7 μg/ml dsRNA-analogue polyinosinic-
polycytidylic acid (poly I:C) (Sigma-Aldrich) using Lipo-
fectamine™ 2000 (Invitrogen) for 1 h or left untreated.
The cells were collected and washed with PBS before
they were lysed with HEPES lysis buffer (50 mM HEPES,
150 mM NaCl, 1 mM EDTA, 1% NP-40, pH 7.4) includ-
ing protease and phosphatase inhibitor cocktails (Sigma-
Aldrich). The cell lysates were centrifuged 11,686 × g for
15 min at 4°C and the protein content was measured
with Bio-Rad DC™ protein assay (Bio-Rad). For the sam-
ples, 8 mg of protein was used. The proteins were pre-
cipitated with 10% TCA/acetone and resuspended in
1 ml of urea buffer (8 M urea, 400 mM NH4CO3,
20 mM DL-dithiotheitol, 1 mM EDTA, pH 8.5). The pro-
teins were reduced, alkylated and enzymatically digested
in-solution with lysyl endopeptidase (7.5 μg/sample,
rLys-C Mass Spec Grade, Promega) for 2 hrs, which
after the samples were diluted with 7 ml of destilled
water, followed by digestion with trypsin (20 μg/sample,
Sequencing Grade Modified Trypsin, Promega) for
16 hrs. Undigested proteins and cell debris were re-
moved, and the samples were desalted on Sep-Pak Vac
RP C18 cartridges (Waters). The peptides were fraction-
ated by SCX-HPLC, using an ÄKTApurifier™ instrument
(Amersham Biosciences). The peptides were separated ona 200 × 4.6 mm, 5 μm, 200 Å PolySULFOETHYL A™ col-
umn (PolyLC) by applying a gradient run with increasing
salt concentration. The A buffer contained 10 mM
KH2PO4, 20% acetonitrile, with a pH < 3. The gradient
was set to 0–50% buffer B (buffer A + 0.4 M KCl) in
25 min, followed by 50–100% buffer B in 15 min. The flow
rate was 1 ml/min and 1 ml fractions were collected by an
autosampler. The SCX-fractions containing phosphopep-
tides were collected and desalted. Phosphopeptide enrich-
ment was performed with IMAC using PHOS-Select™
Iron Affinity Gel (Sigma Aldrich) and SigmaPrep™ spin
columns according to the manufacturer’s instruction. The
enriched phosphopeptides were vacuum-dried and dis-
solved in 0.1% TFA, which after analyzed by nanoLC-MS/
MS using an Ultimate 3000 nano-LC (Dionex) coupled to
a QSTAR Elite hybrid quadrupole TOF-MS (Applied Bio-
systems/MDS Sciex) with nano-ESI ionization as previ-
ously described [17,32]. The samples were loaded on a
ProteCol C18-Trap column (SGE) and separated on a
PepMap C18 analytical column (15 cm × 75 μm, 5 μm,
100 Å) (LC Packings/Dionex) at 200 nl/min with a linear
gradient of 0–40% acetonitrile in 120 min. The MS data
was acquired with Analyst QS 2.0 software. Information-
dependent acquisition method consisted of a 0.5 s TOF-
MS survey scan of m/z 400–1400. From every survey scan
two most abundant ions with charge states +2 to +4 were
selected for product ion scans, and each selected target
ion was dynamically excluded for 60 s. Smart IDA was ac-
tivated with automatic collision energy and automatic
MS/MS accumulation. The LC-MS/MS data were submit-
ted through the ProteinPilot 4.0 interface (Applied Biosys-
tems/MDS Sciex) to an in-house Mascot database search
engine version 4.0 (Matrix Science), and to the ProteinPi-
lot algorithm Paragon. The data were searched against the
human canonical sequences in the Swiss-Prot database
(version 01032013 with 539,616 sequences for the Mascot
searches and version 01042013 with 539,829 sequences
for the Paragon searches). Similar search criteria for both
Mascot and Paragon were used and the criteria are listed,
together with the original searches, as Additional file 1:
Table S1. For additional confidence of the peptide identifi-
cations, the Mascot search results were filtered with an
ion score expected cut-off value of 0.01, and the Para-
gon search results with a peptide confidence level of
99%. The raw data, together with the original Mascot
and Paragon searches, has been deposited to the Pro-
teomeXchange Consortium (http://proteomecentral.pro-
teomexchange.org) via the PRIDE partner repository [33]
with the dataset identifier PXD000577.
Quantitative phosphoproteome samples
Published iTRAQ datasets [21] were used for the imple-
mentation and testing of the quantitative data support in
PhosFox. As described in the original publication [21],
Söderholm et al. Proteome Science 2014, 12:36 Page 9 of 10
http://www.proteomesci.com/content/12/1/36rat inner medullary collecting duct samples were incu-
bated with or without dDAVP, a V2 receptor-analog of
vasopressin, at four different time points (0.5, 2, 5 and
15 min). The proteins were enzymatically digested and
each peptide sample was labeled with 8-plex iTRAQ re-
agent. The labeled samples were combined into a single
sample before SCX fractionation, Ga3+ IMAC, and LC-
MS/MS analysis with a LTQ Orbitrap Velos mass spec-
trometer (Thermo Scientific). The MS/MS data was
searched with the Sequest algorithm through the Proteome
Discoverer platform (Thermo Scientific) on a concatenated
database of the Rat Refseq Database (NCBI, March 3,
2010, 30,734 entries), and the abundance ratios (dDAVP/
control) for the four time points were calculated. The
15 min time point from one of the three biological repli-
cates was analyzed with PhosFox and compared to the ori-
ginal results (Additional file 7: Figure S1).Additional files
Additional file 1: Table S1. The database search results for the
qualitative phosphoproteomic case study example.
Additional file 2: Table S2. The number of unphosphorylated and
phosphorylated peptide spectral matches (PSMs) of the qualitative
phosphoproteomics case study example identified by Mascot and Paragon
search engines in the different samples (control and case) and biological
replicates (I-II). A threshold of 99% peptide confidence for the Paragon
results and an ion score cut-off of 0.01 for the Mascot results were applied.
Additional file 3: Table S3. The PhosFox reports of phosphorylated and
acetylated peptides for the qualitative phosphoproteomic case study example.
Additional file 4: Table S4. Results from the qualitative
phosphoproteomic case study example processed with PhosFox: The
Mascot and Paragon peptide and phosphosite identifications from the
control and case samples. The phosphosite is indicated as the amino acid
number on the total protein sequence and the type of amino acid
carrying the phospho-group as a letter (S, T, Y or K).
Additional file 5: Table S5. Results from the qualitative
phosphoproteomic case study example processed with PhosFox: the
unique phosphoproteins identified from the control and case samples by
Mascot and Paragon.
Additional file 6: Table S6. Mascot and Paragon confidence scores for
the acetylated peptides identified by PhosFox in the qualitative
phosphoproteomic case example.
Additional file 7: Figure S1. The quantitative phosphoproteomic case
study example. Previously published quantitative phosphoproteomic data
from rat kidney inner medulla [21] of the 15 min time point from one of
the three biological replicates was analyzed. The manually compiled
search results are represented as a Venn diagram on the left and the
PhosFox processed results as Venn diagrams on the right. Cutoff values
of > 1.414 for the case peptides and < 0.707 for the control peptides were
applied. With manual compilation, a total of 2,094 phosphoproteins for
the case sample and 2,087 phosphoproteins for the control sample were
identified. From these, 2,002 phosphoproteins were identical between
the samples. With PhosFox, 325 unique phosphopeptides for the case
sample and 344 unique phosphopeptides for the control sample were
identified. In total, 4,025 phosphopeptides were identical between the
samples. By taking into account the sample-unique phosphopeptides, 282
uniquely phosphorylated case proteins and 299 uniquely phosphorylated
control proteins were identified. From these, 52 proteins had differences in
phosphorylation sites between the case and control samples.Additional file 8: Table S7. The KEA kinase enrichment analysis results
for the PhosFox-processed control and case datasets from the qualitative
case study example.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SS carried out the experimental case study, helped with the development of
the software and drafted the manuscript. PH implemented the PhosFox
application, wrote the code and helped to draft the manuscript. TÖ participated
in developing PhosFox. TA and TN conceived and designed the experiments
and wrote the manuscript. All authors read and approved the final manuscript.
Acknowledgements
The authors thank Dr. Mark Knepper and Dr. Jason Hoffert for providing the
quantitative phosphoproteomic datasets. This work was supported by the
Academy of Finland [grant numbers 135628, 140950, 255842, 272931,
133227, 269862, 134020, and 218310]; the Sigrid Jusélius foundation, and the
Integrative Life Science Doctoral Program (ILS) at the University of Helsinki.
Author details
1Institute of Biotechnology, University of Helsinki, P.O. Box 65 (Viikinkaari 1),
FI-00014 Helsinki, Finland. 2Institute for Molecular Medicine Finland (FIMM),
University of Helsinki, Helsinki, Finland.
Received: 26 March 2014 Accepted: 19 June 2014
Published: 26 June 2014
References
1. Lemeer S, Heck AJ: The phosphoproteomics data explosion. Curr Opin
Chem Biol 2009, 13(4):414–420.
2. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS: Probability-based protein
identification by searching sequence databases using mass
spectrometry data. Electrophoresis 1999, 20(18):3551–3567.
3. Eng JK, McCormack AL, Yates JRI: An approach to correlate tandem mass
spectral data of peptides with amino acid sequences in a protein
database. J Am Soc Mass Spectrom 1994, 5:976–989.
4. Craig R, Beavis RC: TANDEM: matching proteins with tandem mass
spectra. Bioinformatics 2004, 20(9):1466–1467.
5. Geer LY, Markey SP, Kowalak JA, Wagner L, Xu M, Maynard DM, Yang X, Shi
W, Bryant SH: Open mass spectrometry search algorithm. J Proteome Res
2004, 3(5):958–964.
6. Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M:
Andromeda: a peptide search engine integrated into the MaxQuant
environment. J Proteome Res 2011, 10(4):1794–1805.
7. Shilov IV, Seymour SL, Patel AA, Loboda A, Tang WH, Keating SP, Hunter CL,
Nuwaysir LM, Schaeffer DA: The Paragon Algorithm, a next generation
search engine that uses sequence temperature values and feature
probabilities to identify peptides from tandem mass spectra. Mol Cell
Proteomics 2007, 6(9):1638–1655.
8. Jiang X, Ye M, Cheng K, Zou H: ArMone: a software suite specially
designed for processing and analysis of phosphoproteome data.
J Proteome Res 2010, 9(5):2743–2751.
9. Courcelles M, Lemieux S, Voisin L, Meloche S, Thibault P:
ProteoConnections: a bioinformatics platform to facilitate proteome and
phosphoproteome analyses. Proteomics 2011, 11(13):2654–2671.
10. Bennetzen MV, Cox J, Mann M, Andersen JS: PhosphoSiteAnalyzer: a
bioinformatic platform for deciphering phospho proteomes using kinase
predictions retrieved from NetworKIN. J Proteome Res 2012, 11(6):3480–3486.
11. Yu K, Salomon AR: PeptideDepot: flexible relational database for visual
analysis of quantitative proteomic data and integration of existing
protein information. Proteomics 2009, 9(23):5350–5358.
12. Savitski MM, Lemeer S, Boesche M, Lang M, Mathieson T, Bantscheff M,
Kuster B: Confident phosphorylation site localization using the Mascot
Delta Score. Mol Cell Proteomics 2011, 10(2):M110.003830.
13. Taus T, Kocher T, Pichler P, Paschke C, Schmidt A, Henrich C, Mechtler K:
Universal and confident phosphorylation site localization using
phosphoRS. J Proteome Res 2011, 10(12):5354–5362.
Söderholm et al. Proteome Science 2014, 12:36 Page 10 of 10
http://www.proteomesci.com/content/12/1/3614. Lietzen N, Natri L, Nevalainen OS, Salmi J, Nyman TA: Compid: a new
software tool to integrate and compare MS/MS based protein
identification results from Mascot and Paragon. J Proteome Res 2010,
9(12):6795–6800.
15. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S,
Khainovski N, Pillai S, Dey S, Daniels S, Purkayastha S, Juhasz P, Martin S,
Bartlet-Jones M, He F, Jacobson A, Pappin DJ: Multiplexed protein
quantitation in Saccharomyces cerevisiae using amine-reactive isobaric
tagging reagents. Mol Cell Proteomics 2004, 3(12):1154–1169.
16. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, Mann
M: Stable isotope labeling by amino acids in cell culture, SILAC, as a
simple and accurate approach to expression proteomics. Mol Cell
Proteomics 2002, 1(5):376–386.
17. Ohman T, Lietzen N, Valimaki E, Melchjorsen J, Matikainen S, Nyman TA:
Cytosolic RNA recognition pathway activates 14-3-3 protein mediated
signaling and caspase-dependent disruption of cytokeratin network in
human keratinocytes. J Proteome Res 2010, 9(3):1549–1564.
18. Villen J, Gygi SP: The SCX/IMAC enrichment approach for global
phosphorylation analysis by mass spectrometry. Nat Protoc 2008,
3(10):1630–1638.
19. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M:
Global, in vivo, and site-specific phosphorylation dynamics in signaling
networks. Cell 2006, 127(3):635–648.
20. Luo R, Fang L, Jin H, Wang D, An K, Xu N, Chen H, Xiao S: Label-free
quantitative phosphoproteomic analysis reveals differentially regulated
proteins and pathway in PRRSV-infected pulmonary alveolar macro-
phages. J Proteome Res 2014, 13(3):1270–1280.
21. Hoffert JD, Pisitkun T, Saeed F, Song JH, Chou CL, Knepper MA: Dynamics
of the G protein-coupled vasopressin V2 receptor signaling network
revealed by quantitative phosphoproteomics. Mol Cell Proteomics 2012,
11(2):M111.014613.
22. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N,
Schwikowski B, Ideker T: Cytoscape: a software environment for
integrated models of biomolecular interaction networks. Genome Res
2003, 13(11):2498–2504.
23. Lachmann A, Ma'ayan A: KEA: kinase enrichment analysis. Bioinformatics
2009, 25(5):684–686.
24. Kawakami T, Kawakami Y, Kitaura J: Protein kinase C beta (PKC beta):
normal functions and diseases. J Biochem 2002, 132(5):677–682.
25. Timm T, Marx A, Panneerselvam S, Mandelkow E, Mandelkow EM: Structure
and regulation of MARK, a kinase involved in abnormal phosphorylation
of Tau protein. BMC Neurosci 2008, 9(Suppl 2):S9. http://www.ncbi.nlm.nih.
gov/pubmed/19090997.
26. Davis AJ, Lee KJ, Chen DJ: The N-terminal region of the DNA-dependent
protein kinase catalytic subunit is required for its DNA double-stranded
break-mediated activation. J Biol Chem 2013, 288(10):7037–7046.
27. Melchjorsen J, Sorensen LN, Paludan SR: Expression and function of
chemokines during viral infections: from molecular mechanisms to
in vivo function. J Leukoc Biol 2003, 74(3):331–343.
28. Mikkelsen SS, Jensen SB, Chiliveru S, Melchjorsen J, Julkunen I, Gaestel M,
Arthur JS, Flavell RA, Ghosh S, Paludan SR: RIG-I-mediated activation of
p38 MAPK is essential for viral induction of interferon and activation of
dendritic cells: dependence on TRAF2 and TAK1. J Biol Chem 2009,
284(16):10774–10782.
29. Stahl JA, Chavan SS, Sifford JM, Macleod V, Voth DE, Edmondson RD, Forrest
JC: Phosphoproteomic analyses reveal signaling pathways that facilitate
lytic gammaherpesvirus replication. PLoS Pathog 2013, 9(9):e1003583.
30. Wojcechowskyj JA, Didigu CA, Lee JY, Parrish NF, Sinha R, Hahn BH,
Bushman FD, Jensen ST, Seeholzer SH, Doms RW: Quantitative
phosphoproteomics reveals extensive cellular reprogramming during
HIV-1 entry. Cell Host Microbe 2013, 13(5):613–623.
31. Popova TG, Turell MJ, Espina V, Kehn-Hall K, Kidd J, Narayanan A, Liotta L,
Petricoin EF 3rd, Kashanchi F, Bailey C, Popov SG: Reverse-phase
phosphoproteome analysis of signaling pathways induced by Rift
valley fever virus in human small airway epithelial cells. PLoS One 2010,
5(11):e13805.32. Lietzen N, Ohman T, Rintahaka J, Julkunen I, Aittokallio T, Matikainen S,
Nyman TA: Quantitative subcellular proteome and secretome profiling of
influenza A virus-infected human primary macrophages. PLoS Pathog
2011, 7(5):e1001340.
33. Vizcaino JA, Cote RG, Csordas A, Dianes JA, Fabregat A, Foster JM, Griss J,
Alpi E, Birim M, Contell J, O’Kelly G, Schoenegger A, Ovelleiro D, Perez-
Riverol Y, Reisinger F, Rios D, Wang R, Hermjakob H: The PRoteomics
IDEntifications (PRIDE) database and associated tools: status in 2013.
Nucleic Acids Res 2013, 41(Database issue):D1063–D1069.
doi:10.1186/1477-5956-12-36
Cite this article as: Söderholm et al.: PhosFox: a bioinformatics tool for
peptide-level processing of LC-MS/MS-based phosphoproteomic data.
Proteome Science 2014 12:36.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
